Skip to main navigation Investor FAQs Show All What does Exagen do? We are dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. We have developed and are commercializing a portfolio of innovative testing products under our AVISE® brand, several of which are based on our proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology. CB-CAPs assess the activation of the complement system, a biological pathway that is widely implicated across many autoimmune and autoimmune related diseases, including systemic lupus erythematosus, or SLE. Our goal is to enable rheumatologists to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including SLE and rheumatoid arthritis, or RA. Our strategy includes leveraging our portfolio of testing products to market therapeutics through our sales channel and targeting the approximately 5,000 rheumatologists across the United States. Our business model of integrating testing products and therapeutics positions us to offer targeted solutions to rheumatologists and, ultimately, better serve patients. Where is Exagen incorporated? Where is Exagen’s corporate headquarters? On what exchange does Exagen’s stock trade? What is Exagen’s stock ticker? What is Exagen’s CUSIP number? Who is Exagen’s transfer agent, and how do I contact them? Does Exagen pay a dividend? How can I purchase Exagen common stock? Does Exagen have a direct stock purchase plan? Whom do I contact with questions about my stock? What is Exagen’s fiscal year-end? Who is Exagen’s independent registered public accounting firm? Who is Exagen’s legal counsel? Who makes up the Exagen Management team and Board of Directors? Does Exagen have a corporate governance program? When is your next earnings release? How can I get copies of financial documents on the company, including quarterly reports (Form 10-Q) and annual reports (Form 10-K)? How can I receive financial update emails? How can I find out more about upcoming events? How do I contact EXAGEN Investor Relations? Print Page Email Alerts RSS Feeds Investor Contacts © 2021 Exagen Inc. | All Rights Reserved SA1168 Footer